IBDEI1K2 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25214,1,2,0)
 ;;=2^96376
 ;;^UTILITY(U,$J,358.3,25214,1,3,0)
 ;;=3^Tx/Pro/Dx Inj,ea addl sequential IVP of Same Drug-Add-on
 ;;^UTILITY(U,$J,358.3,25215,0)
 ;;=J2680^^91^1143^5^^^^1
 ;;^UTILITY(U,$J,358.3,25215,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25215,1,2,0)
 ;;=2^J2680
 ;;^UTILITY(U,$J,358.3,25215,1,3,0)
 ;;=3^Fluphenazine Decanoate up to 25mg
 ;;^UTILITY(U,$J,358.3,25216,0)
 ;;=J1631^^91^1143^6^^^^1
 ;;^UTILITY(U,$J,358.3,25216,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25216,1,2,0)
 ;;=2^J1631
 ;;^UTILITY(U,$J,358.3,25216,1,3,0)
 ;;=3^Haloperidol Decanoate per 50mg
 ;;^UTILITY(U,$J,358.3,25217,0)
 ;;=J2315^^91^1143^7^^^^1
 ;;^UTILITY(U,$J,358.3,25217,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25217,1,2,0)
 ;;=2^J2315
 ;;^UTILITY(U,$J,358.3,25217,1,3,0)
 ;;=3^Naltrexone,Depot Form 1mg
 ;;^UTILITY(U,$J,358.3,25218,0)
 ;;=J2426^^91^1143^9^^^^1
 ;;^UTILITY(U,$J,358.3,25218,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25218,1,2,0)
 ;;=2^J2426
 ;;^UTILITY(U,$J,358.3,25218,1,3,0)
 ;;=3^Paliperidone Palmitate Extend Release per 1mg
 ;;^UTILITY(U,$J,358.3,25219,0)
 ;;=J2794^^91^1143^10^^^^1
 ;;^UTILITY(U,$J,358.3,25219,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25219,1,2,0)
 ;;=2^J2794
 ;;^UTILITY(U,$J,358.3,25219,1,3,0)
 ;;=3^Risperidone Long Act per 0.5mg
 ;;^UTILITY(U,$J,358.3,25220,0)
 ;;=J2315^^91^1143^11^^^^1
 ;;^UTILITY(U,$J,358.3,25220,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25220,1,2,0)
 ;;=2^J2315
 ;;^UTILITY(U,$J,358.3,25220,1,3,0)
 ;;=3^Vivitrol 1mg
 ;;^UTILITY(U,$J,358.3,25221,0)
 ;;=J0401^^91^1143^1^^^^1
 ;;^UTILITY(U,$J,358.3,25221,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25221,1,2,0)
 ;;=2^J0401
 ;;^UTILITY(U,$J,358.3,25221,1,3,0)
 ;;=3^Aripiprazole Ext Rel 1mg
 ;;^UTILITY(U,$J,358.3,25222,0)
 ;;=J2358^^91^1143^8^^^^1
 ;;^UTILITY(U,$J,358.3,25222,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25222,1,2,0)
 ;;=2^J2358
 ;;^UTILITY(U,$J,358.3,25222,1,3,0)
 ;;=3^Olanzapine,Long-Acting 1mg
 ;;^UTILITY(U,$J,358.3,25223,0)
 ;;=J1943^^91^1143^2^^^^1
 ;;^UTILITY(U,$J,358.3,25223,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25223,1,2,0)
 ;;=2^J1943
 ;;^UTILITY(U,$J,358.3,25223,1,3,0)
 ;;=3^Aristada Initio 1mg
 ;;^UTILITY(U,$J,358.3,25224,0)
 ;;=Q9991^^91^1143^3^^^^1
 ;;^UTILITY(U,$J,358.3,25224,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25224,1,2,0)
 ;;=2^Q9991
 ;;^UTILITY(U,$J,358.3,25224,1,3,0)
 ;;=3^Buprenorphine Ext-Release (Sublocade),up to 100mg
 ;;^UTILITY(U,$J,358.3,25225,0)
 ;;=Q9992^^91^1143^4^^^^1
 ;;^UTILITY(U,$J,358.3,25225,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25225,1,2,0)
 ;;=2^Q9992
 ;;^UTILITY(U,$J,358.3,25225,1,3,0)
 ;;=3^Buprenorphine Ext-Release (Sublocade) > 100mg    
 ;;^UTILITY(U,$J,358.3,25226,0)
 ;;=96156^^91^1144^1^^^^1
 ;;^UTILITY(U,$J,358.3,25226,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25226,1,2,0)
 ;;=2^96156
 ;;^UTILITY(U,$J,358.3,25226,1,3,0)
 ;;=3^Hlth/Behav,Assess/Reassess,Ea 15 min
 ;;^UTILITY(U,$J,358.3,25227,0)
 ;;=96158^^91^1144^2^^^^1
 ;;^UTILITY(U,$J,358.3,25227,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25227,1,2,0)
 ;;=2^96158
 ;;^UTILITY(U,$J,358.3,25227,1,3,0)
 ;;=3^Hlth/Behav Interv,Indiv,Init 30 min
 ;;^UTILITY(U,$J,358.3,25228,0)
 ;;=96159^^91^1144^3^^^^1
 ;;^UTILITY(U,$J,358.3,25228,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25228,1,2,0)
 ;;=2^96159
 ;;^UTILITY(U,$J,358.3,25228,1,3,0)
 ;;=3^Hlth/Behav Interv,Indiv,Ea Addl 15 min
